Dr. Schwartz answers the question: 'Difference between in situ breast cancers?' — -- Question: What is the difference between ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS)?

Actress Danielle Fishel shared her breast cancer diagnosis this week, revealing on Monday's episode of her podcast, "Pod Meets World," that she is being treated for ductal carcinoma in situ (DCIS).

The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...

Invasive lobular carcinoma accounts for about 10% of breast cancer diagnoses. Its incidence is increasing at the rate of 2.8% annually -- more than triple that of other breast cancers combined. This ...

I am a radiation oncologist and was recently referred a 71-year-old woman, diagnosed in October 2003 with a multifocal invasive ductal carcinoma (1.9 and 0.9 cm) -- grade 2, estrogen-receptor ...

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the pancreatic duct.

The leaders of the MSK Lobular Breast Cancer program (from left), breast pathologist Fresia Pareja, MD, PhD; breast surgeon Anita Mamtani, MD; breast medical oncologist Sherry Shen, MD. The program is ...

Please provide your email address to receive an email when new articles are posted on . Chronic HCV infection was associated with a 1.8-fold increased risk for pancreatic ductal adenocarcinoma.